Liver Function & Health Testing

The liver is a busy organ that helps process nutrients, filter the blood, build proteins, and clear waste. Because so much of that work leaves a chemical trace, a blood sample can carry information about several aspects of liver activity at once. This is why a common starting point is a bundled panel rather than a single marker.

Broadly, liver tests fall into a few groups. Enzymes such as ALT, AST, alkaline phosphatase, and GGT are substances found in liver and related tissues that can rise in the blood when cells are stressed or irritated. Bilirubin is a yellow pigment left over as the body recycles old red blood cells, and the liver normally helps clear it. Proteins such as albumin and total protein reflect part of what the liver builds. Each group describes a different piece of the same system.

Liver enzymes are among the most familiar markers. Clinicians associate certain patterns across ALT, AST, ALP, and GGT with different kinds of stress on the liver or the bile ducts, which is why these are usually read as a group rather than one at a time. A single enzyme rarely tells the whole story on its own.

Bilirubin adds another layer. It can be measured as a total figure or split into fractions — often described as direct and indirect — which helps a clinician think about where in the processing pathway a change might sit. Proteins the liver makes, such as albumin, speak more to its longer-term building work. Together these markers let a clinician look at both short-term irritation and steadier functions in the same sample.

Fatty liver — increasingly discussed under names such as NAFLD, and more recently MASLD (metabolic dysfunction-associated steatotic liver disease) — has become a common subject in general health conversations. In broad terms, it refers to fat building up in liver tissue, and it is often connected in the medical literature to metabolic factors like weight, blood sugar, and lipids.

Because it is frequently discussed alongside routine bloodwork, many people come across the topic when reviewing enzyme results with a clinician. This page is not a way to diagnose or rule out any liver condition; it simply explains what the markers describe. Whether a given result means anything for an individual is a question only a clinician can answer, using the full picture.

For many years, assessing scarring in the liver — known as fibrosis — meant a biopsy. Noninvasive blood panels have added another option that clinicians may consider. FibroTest, sometimes paired with ActiTest, is one such panel: it combines several routine blood markers through a calculation to give a clinician information about the likelihood and degree of fibrosis, without a tissue sample.

These panels are tools that support a clinician's thinking rather than stand-alone answers. They are typically read alongside enzyme and bilirubin results, imaging, and a person's history. As with every marker discussed here, a clinician decides whether such a panel adds anything useful for a particular individual and how to weigh what it shows.

Liver testing uses a routine blood draw. After ordering online, you visit a patient service center to have the sample collected — often without an appointment — and a phlebotomist handles the draw, which takes only a few minutes. Some tests have preparation instructions, so it is worth reading the details for whatever you order and mentioning any medications to your clinician.

A liver result is a data point, not a diagnosis. Enzymes and pigments can shift with recent illness, activity, medications, and many other factors, which is why a clinician reads results against your history and other markers before drawing conclusions. Thinking of results as information to discuss — rather than an answer in themselves — is the most reliable way to make use of them.